The Therapeutic Monoclonal Antibody Pemivibart Causes Persistent Interference in Immunofixation Electrophoresis
- 4 February 2025
- journal article
- Published by Oxford University Press (OUP) in The Journal of Applied Laboratory Medicine
- Vol. 10 (3) , 771-774
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- New Guidance Helps Clinicians Use Pemivibart to Protect Immunocompromised Patients From COVID-19JAMA, 2024
- Belimumab Is an IgG Lambda Therapeutic Monoclonal Antibody with the Potential to Cause Misdiagnosis of a Monoclonal GammopathyClinical Chemistry, 2024
- International nonproprietary names for monoclonal antibodies: an evolving nomenclature systemmAbs, 2022